GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

por Rasalam, Roy, Barlow, John, Kennedy, Mark, Phillips, Pat, Wright, Alan
Publicado 2019

Improving Type 2 Diabetes Management in General Practice Using a Second-Generation Basal Insulin Analogue Insulin Glargine 300 U/mL: A  Practical Guide

por Deed, Gary, Rasalam, Roy, Khoo, Chee, Dover, Tom, Forgione, Nick
Publicado 2019

Effective primary care management of type 2 diabetes for indigenous populations: A systematic review

por Chopra, Sahil, Lahiff, Tahne Joseph, Franklin, Richard, Brown, Alex, Rasalam, Roy
Publicado 2022

Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

por Deed, Gary, Atherton, John J., d’Emden, Michael, Rasalam, Roy, Sharma, Anita, Sindone, Andrew
Publicado 2019

Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review

por Rasalam, Roy, Atherton, John J., Deed, Gary, Molloy‐Bland, Michael, Cohen, Neale, Sindone, Andrew
Publicado 2021

Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First-in-Class Twincretin

por MacIsaac, Richard J., Deed, Gary, D’Emden, Michael, Ekinci, Elif I., Hocking, Samantha, Sumithran, Priya, Rasalam, Roy
Publicado 2023